From J&J oncology chief to tiny biotech startup CEO? Serge Messerlian talks about his big career changeup

San Francisco-based Teon Therapeutics got itself a new CEO — in a transition from Big Pharma into the world of biotech. But what sparked that transition isn’t so rosy. The catalyst for the change was when Serge Messerlian’s father passed away last year from renal cancer. “You know, like those…

...

Click to view original post